PROVIDING SPECIALIZED MEDICAL CARE TO PATIENTS WITH VIRAL PNEUMONIA CAUSED BY SARS-COV-2

Abstract

The main complication of the new coronavirus infection is viral pneumonia caused by SARS-CoV-2, which alone or in combination with other pathology determines the main need for specialized medical care provided in inpatient settings, and occupies the main share in the structure of all hospitalized patients (Esipov A. V. et al., 2020; Tyurin I. E. et al., 2020; Furman E. G. et al., 2020). This, in its turn, requires appropriate conditions for providing medical care, additional resources, cardinal restructuring of the activities of infectious disease hospitals and medical organizations reoriented to them. SARS- CV-2 virus infection remains largely unexplored. However, clinical research of a prognostic nature is essential, which will improve the quality of diagnosis and prevent adverse outcomes of the disease. One of the most relevant areas is HLA genotyping.